HKU Scholars Hub: Browsing DSpace

Browsing by Author Bzowej, N

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 13 of 13

	Title	Author(s)	Issue Date
	2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B Journal:Gastroenterology	Liaw, Y Gane, E Leung, N Zeuzem, S Wang, Y Lai, CL Heathcote, EJ Manns, M Bzowej, N Niu, J Han, S Hwang, SG Cakaloglu, Y Tong, MJ Papatheodoridis, G Chen, Y Brown, NA Albanis, E Galil, K Naoumov, NV	2009
	Effect of core promoter/precore mutation pattern and early virologic response on efficacy outcomes with telbivudine in HBeAg-negative chronic hepatitis B Proceeding/Conference:Journal of Hepatology	Naoumov, N Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Heathcote, EJ Rasenack, J Bzowej, N Chao, G Brown, N	2006
	Maximal early HBV suppression is predictive of optimal virologic and clinical efficacy in nucleoside-treated hepatitis B patients: scientific observations from a large multinational trial (the GLOBE study) Proceeding/Conference:Hepatology	Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Chen, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N the GLOBE Study Group	2005
	Optimal virologic and clinical efficacy at one year is associated with maximal early HBV suppression in nucleoside-treated hepatitis B patients Proceeding/Conference:Journal of Hepatology	Zeuzem, S Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Chen, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N	2006
	Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year Proceeding/Conference:Journal of Hepatology	Gane, E Lai, CL Liaw, YF Thongsawat, S Wang, YM Cheng, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N	2006
	Phase III Comparison of Telbivudine vs Lamivudine in Patients with Chronic Hepatitis B: Efficacy, Safety, and Predictors of Response at 1 Year Proceeding/Conference:Gastroenterology	Bzowej, N Lai, CL Gane, E Liaw, Y Thongsawat, S Wang, Y Chen, Y Heathcote, J Rasenack, J Naoumov, N Chao, G Fielman, B Brown, N	2006
	Prolonged efficacy and safety of 3 years of continuous telbivudine treatment in pooled data from globe and 015 studies in chronic hepatitis B patients Proceeding/Conference:Journal of Hepatology	Hsu, CW Chen, YC Liaw, YF Gane, E Manns, M Zeuzem, S Wang, Y Lai, CL Hou, J Leung, N Bzowej, N Niu, J Jia, J Hwang, SG Cakaloglu, Y Ren, H Papatheodoridis, G Chen, Y Bao, W Lopez, P	2009
	A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Final Week 52 results Proceeding/Conference:Hepatology	Bzowej, N Chan, HLY Lai, CL Cho, M Moon, YM Chao, YC Heathcote, EJ Myers, R Minuk, G Marcellin, P Jeffers, L Sievert, W Kaiser, R Harb, G Chao, GC Brown, NA	2006
	Telbivudine (LdT) vs. lmivudine for chronic Hepatitis B: First-year results from the international phase III GLOBE trial Proceeding/Conference:Hepatology	Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Chen, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N and the GLOBE Study Group, .	2005
	Telbivudine Globe Trial: Maximal Early HBV Suppression is Predictive of Optimal Two-year Efficacy in Nucleoside-treated Hepatitis B Patients Proceeding/Conference:Hepatology	DiBisceglie A, A Lai, CL Gane, E Chen, YC Thongsawat, S Wang, YM Chen, YG Heathcote, EJ Zeuzem, S Rasenack, J Bzowej, N Han, SH Naoumov, N Hwang, SG Lim, SG Chao, GC Fielman, BA Brown, NA Study Group The GLOBE,	2006
	Telbivudine versus lamivudine in patients with chronic hepatitis B Journal:New England Journal of Medicine	Lai, CL Gane, E Liaw, YF Hsu, CW Thongsawat, S Wang, Y Chen, Y Heathcote, EJ Rasenack, J Bzowej, N Naoumov, NV Di Bisceglie, AM Zeuzem, S Moon, YM Goodman, Z Chao, G Constance, BF Brown, NA	2007
	Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial Journal:Annals of Internal Medicine	Chan, HLY Heathcote, EJ Marcellin, P Lai, CL Cho, M Moon, YM Chao, YC Myers, RP Minuk, GY Jeffers, L Sievert, W Bzowej, N Harb, G Kaiser, R Qiao, XJ Brown, NA Crawford, D Lim, SG Chutaputti, A Poynard, T	2007
	Two-year Results from the Globe Trial in Patients with Hepatitis B: Greater Clinical and Antiviral Efficacy for Telbivudine (LdT) vs Lamivudine Proceeding/Conference:Hepatology	Lai, CL Gane, E Hsu, CW Thongsawat, S Wang, YM Chen, YG Heathcote, EJ Rasenack, J Bzowej, N Naoumov, N Zeuzem, S Di Bisceglie, A Chao, GC Barbara, A Constance, F Brown, NA Study Group The GLOBE.,	2006

Showing results 1 to 13 of 13